Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

CUSIP: 03836J201

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
9,144,889
Total 13F shares
1,695,512
Share change
+66,461
Total reported value
$1,446,275
Price per share
$0.85
Number of holders
22
Value change
-$113,007
Number of buys
9
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 03836J201?
CUSIP 03836J201 identifies APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q4 2025

As of 31 Dec 2025, Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,695,512 shares. The largest 10 holders included AIGH Capital Management LLC, Murchinson Ltd., SPHERA FUNDS MANAGEMENT LTD., Nantahala Capital Management, LLC, DRW Securities, LLC, MORGAN STANLEY, VANGUARD GROUP INC, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.